News
-
-
-
-
-
-
-
-
PRESS RELEASE
1upHealth Launches Customer Advisory Board to Advance Industry-Wide Interoperability and Fuel Technological Innovation
1upHealth forms Customer Advisory Board (CAB) with executives from leading health plans to enhance company solutions and drive industry innovation. The CAB will advise on business strategies and product roadmap for optimizing interoperability -
-
PRESS RELEASE
Two Investigator-Initiated Responder Analysis Trials of Jaguar Health's Crofelemer Show Significant Positive Results for Chronic Refractory Diarrhea in IBS-D: Data Accepted for Presentation at American College of Gastroenterology 2024 Annual Meeting
Napo Pharmaceuticals announced positive results of studies on crofelemer for chronic refractory diarrhea at the ACG Annual Scientific Meeting. The drug may benefit patients with functional diarrhea and chronic idiopathic diarrhea